New facility will provide end-to-end solution to accelerate cell therapy development and manufacturing WALTHAM, Mass. and SAN FRANCISCO, May 19, 2021 -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the agreement, Thermo Fisher will […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Axiom Solutions International, the AI power-and-cooling business Flex Ltd. is carving out...
ByThe RegistryNovember 18, 2026Affiliates of Strada Investment Group and Holland Partner Group have each taken...
ByThe RegistryNovember 18, 2026Symetra Life Insurance Company backed the $15 million purchase of Concord's Salvio...
ByThe RegistryNovember 18, 2026Elevate, the sports and entertainment agency led by San Francisco 49ers Chief...
ByThe RegistryNovember 18, 2026